Substantial increase in fees should increase the top line.They also plan to standardise fees across the country. Which is curious, as their costs must vary.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025